Kura Oncology Files 8-K for Operations Update
Ticker: KURA · Form: 8-K · Filed: Feb 26, 2025 · CIK: 1422143
| Field | Detail |
|---|---|
| Company | Kura Oncology, INC. (KURA) |
| Form Type | 8-K |
| Filed Date | Feb 26, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, operations-update
TL;DR
Kura Oncology filed an 8-K on Feb 26, 2025, updating on operations/financials.
AI Summary
Kura Oncology, Inc. filed an 8-K on February 26, 2025, to report on its results of operations and financial condition. The filing does not contain specific financial figures or operational details in the provided text, but serves as a notification of these updates.
Why It Matters
This filing indicates Kura Oncology is providing an update on its business performance and financial standing to the SEC and its investors.
Risk Assessment
Risk Level: low — This is a standard regulatory filing and does not inherently present new risks based on the provided text.
Key Players & Entities
- Kura Oncology, Inc. (company) — Registrant
- February 26, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 61-1547851 (tax_id) — IRS Employer Identification No.
- 12730 High Bluff Drive, Suite 400, San Diego, CA 92130 (address) — Principal Executive Offices
- (858) 500-8800 (phone_number) — Registrant's Telephone Number
FAQ
What specific financial results or operational updates are being reported by Kura Oncology?
The provided text of the 8-K filing does not contain specific financial figures or detailed operational updates; it only indicates that the filing is related to 'Results of Operations and Financial Condition'.
When was this 8-K filing submitted to the SEC?
The filing was submitted on February 26, 2025.
What is Kura Oncology's principal executive office address?
Kura Oncology's principal executive offices are located at 12730 High Bluff Drive, Suite 400, San Diego, CA 92130.
Under which section of the Securities Exchange Act is this 8-K filed?
This 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is Kura Oncology's IRS Employer Identification Number?
Kura Oncology's IRS Employer Identification Number is 61-1547851.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 26, 2025 regarding Kura Oncology, Inc. (KURA).